Personal BP - CAI Study
ConditionBlood Pressure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45+
SponsorEdwards Lifesciences
About this trial
A single-center, prospective, observational pilot of the Cerebral Adaptive Index for assessing personalized blood pressure targets
Eligibility criteria
Qualifiers
Signed informed consent
Age ≥ 45 years
Planned cardiac surgery with Cardiopulmonary Bypass (CPB)
Planned monitoring with ForeSight sensor and HemoSphere monitor
Disqualifiers
Non-English speaking
Confirmed to be pregnant
Surgery for congenital heart defect
Non-availability of HemoSphere with laptop CAI interface
Trial design
Treatments tested in this trial
- HemoSphere Advanced Monitoring Platform with Acumen IQ sensor and Tissue Oximetry Monitoring
Treatment groups
120 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov